Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality
Konstantinos I. Votanopoulos MD, PhD, Naeem A. Newman MD, Greg Russell MS, Chukwuemeka Ihemelandu MD, Perry Shen MD, John H. Stewart MD, Edward A. Levine MDVolume:
20
Language:
english
DOI:
10.1245/s10434-013-3053-z
Date:
October, 2013
File:
PDF, 452 KB
english, 2013
File converter
More search results
More benefits 
